Background. Features of consumptive coagulopathy and thromboinflammation are prominent in cerebral malaria (CM). We hypothesized that thrombogenic autoantibodies contribute to a procoagulant state in CM.Methods. Plasma from children with uncomplicated malaria (UM, n=124) and CM (n=136) was analyzed by ELISA for a panel of 8 autoantibodies including anti-Platelet Factor 4/polyanion (anti-PF4/P), anti-Phospholipid, anti-Phosphatidylserine, anti-Myeloperoxidase, anti-Proteinase 3, anti-dsDNA, anti-Beta-2-Glycoprotein I (β2GPI), and anti-Cardiolipin. Non-malarial coma (NMC, n=49) and healthy controls (HC, n=56) were assayed for comparison. Associations with clinical and immune biomarkers were determined using univariate and logistic regression analyses.Results. Median anti-PF4/P and anti-PS IgG levels were elevated with malaria infection relative to HC (p<0.001) and NMC (PF4/P: p<0.001). Anti-PF4/P IgG levels were elevated in CM (median=0.27, IQR: 0.19-0.41) compared to UM (median=0.19, IQR: 0.14-0.22, p=<0.0001). Anti-PS IgG levels did not differ between UM and CM (p=0.39). When CM cases were stratified by malaria retinopathy (Ret) status, levels of anti-PF4/P IgG correlated negatively with peripheral platelet count in Ret+ CM cases (Rs= 0.201, p=0.04) and associated positively with mortality (OR=15.2, 95% CI: 1.02 -275, p=0.048).Plasma from CM patients induced greater platelet activation in an ex-vivo assay relative to plasma from UM patients (p=0.02), and the observed platelet activation was associated with anti-PF4/P IgG levels (Rs= 0.293, p=0.035).
Conclusions.Thrombosis mediated by elevated anti-PF4/P autoantibodies may be one mechanism contributing to the clinical complications of CM.